Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ARQT Arcutis Biotherapeutics

Watchlist
16.390
-0.340-2.03%
Close  02/08 16:00 ET
High
16.800
Open
16.740
Turnover
11.90M
Low
16.310
Pre Close
16.730
Volume
721.96K
Market Cap
998.61M
P/E(TTM)
Loss
52wk High
27.400
Shares
60.93M
P/E(Static)
Loss
52wk Low
12.810
Float Cap
760.86M
Bid/Ask %
41.18%
Historical High
40.880
Shs Float
46.42M
Volume Ratio
0.82
Historical Low
12.810
Dividend TTM
--
Div Yield TTM
--
P/B
3.69
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.56%
Amplitude
2.93%
Avg Price
16.478
Lot Size
1
Float Cap
760.86M
Bid/Ask %
41.18%
Historical High
40.880
Shs Float
46.42M
Volume Ratio
0.82
Historical Low
12.810
Dividend TTM
--
P/B
3.69
Dividend LFY
--
Turnover Ratio
1.56%
Amplitude
2.93%
Avg Price
16.478
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
CEO: Mr. Todd Franklin Watanabe
Market: NASDAQ
Listing Date: 01/31/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist